Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer

    Dr. Rachel Grisham MSK ovarian cancer section head discussed clinical trials investigating PARP inhibitors for ovarian cancer patients. The event was a round table discussion and interview for Targeted Oncology.…

    Continue Reading Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer

    Stoke Therapeutics and Acadia Pharmaceuticals Collaborate to Develop Medicines for Rare Neurodevelopmental Disorders

    Stoke Therapeutics and Acadia Pharmaceuticals made a joint announcement this week through Business Wire of their collaboration in the development of RNA-based medicines to potentially treat rare neurodevelopmental disorders of…

    Continue Reading Stoke Therapeutics and Acadia Pharmaceuticals Collaborate to Develop Medicines for Rare Neurodevelopmental Disorders
    A Discussion of von Hippel-Lindau Disease Thirty Years After Discovery
    source: pixabay.com

    A Discussion of von Hippel-Lindau Disease Thirty Years After Discovery

    CURE® recently conducted an interview with von Hippel-Lindau (VHL) patient Joseph Heisler and his mother, Marirene. Joseph’s father was diagnosed thirty years ago with the genetic (inherited) disease. Shortly thereafter…

    Continue Reading A Discussion of von Hippel-Lindau Disease Thirty Years After Discovery

    Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part One

    A group of autoimmune diseases called anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is the subject of a preprint under consideration at Pediatric Rheumatology. ANCA-AAV is characterized by damage to small…

    Continue Reading Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part One

    CRISPR Continues to Cut Impressive Numbers in Beta-Thalassemia, Sickle Cell Disease, and More

    A year ago, Paddy Doherty’s doctor told him that he had a rare hereditary disease called transthyretin (ATTR) amyloidosis, the same disease that had killed his father. As reported in…

    Continue Reading CRISPR Continues to Cut Impressive Numbers in Beta-Thalassemia, Sickle Cell Disease, and More

    Compassion Corner: A Grieving Mother Laments a Lack of Compassion by Nurses When Her Baby Died

    Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…

    Continue Reading Compassion Corner: A Grieving Mother Laments a Lack of Compassion by Nurses When Her Baby Died

    Doctors Receive Nobel Prize for Development in Renal Cell Carcinoma Treatment

    Research by three doctors provided a basis for tyrosine kinase inhibitors (TKI) and offered advancements in treatment for renal cell carcinoma (RCC) patients. Two such TKIs, sunitinib and sorafenib, remain…

    Continue Reading Doctors Receive Nobel Prize for Development in Renal Cell Carcinoma Treatment

    Studies of Head and Neck Cancer Show That Black Patients Have Worse Overall Survival Than Other People of Color

    Researchers are aware that Black cancer patients experience worse outcomes than white cancer patients due to the differences in access to health care. According to a report in Cancer Network,…

    Continue Reading Studies of Head and Neck Cancer Show That Black Patients Have Worse Overall Survival Than Other People of Color
    SEQUOIA Trial Results Show Remarkable Response Rate in High-Risk CLL Subgroup
    source: pixabay.com

    SEQUOIA Trial Results Show Remarkable Response Rate in High-Risk CLL Subgroup

    Targeted Oncology recently featured a discussion by Dr. Jennifer Brown, director of Dana Farber’s Chronic Lymphocytic Leukemia Center, on the interim results from the SEQUOIA Phase 3 trial. The trial…

    Continue Reading SEQUOIA Trial Results Show Remarkable Response Rate in High-Risk CLL Subgroup
    GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant
    Source: Pixabay.com

    GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant

    It is common practice to treat multiple myeloma patients with a stem cell transplant. In the GENESIS trial, the stem cells were autologous (from the patient’s own peripheral blood or bone…

    Continue Reading GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant
    Compassion Corner: A Patient Almost Died Because of a Doctor’s Lack of Understanding and Compassion
    source: pixabay.com

    Compassion Corner: A Patient Almost Died Because of a Doctor’s Lack of Understanding and Compassion

      Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is…

    Continue Reading Compassion Corner: A Patient Almost Died Because of a Doctor’s Lack of Understanding and Compassion